Innovative Motion Technologies Secures New Credit Facility to Support Continued Growth and M&A Strategy
The new financing strengthens the company's capital structure and provides additional flexibility to invest in its vertically integrated platform, expand engineering capabilities, pursue strategic and synergistic acquisitions, and broaden its product offering across key end markets, including healthcare, industrial, HVAC, and utilities. The financing was led by
"This financing enables us to continue investing in the business while expanding our product offering across both existing and new end markets," said
"Since our investment in IMT, the Company has evolved into a differentiated global platform in interface and control technologies, supported by best-in-class engineering and a scaled, diversified footprint across attractive end markets," said
Piper Sandler served as sole debt placement agent on the transaction.
About Innovative Motion Technologies
Innovative Motion Technologies (IMT) is a global industrial technology platform and industry-leading designer and supplier of advanced motion control and interface solutions across a diversified set of OEM and aftermarket applications. The Company operates through a family of brands to deliver highly engineered products across multiple end markets worldwide. For more information, please visit https://imtbrands.com.
About Cathay Capital
Cathay Capital is a global private equity and venture capital investment firm supporting healthcare, technology and consumer companies throughout
Founded in 2007 with a strong entrepreneurial heritage, Cathay Capital now manages more than
For more information, visit: www.cathaycapital.com.
Media Contact:
[email protected]
View original content:https://www.prnewswire.com/news-releases/innovative-motion-technologies-secures-new-credit-facility-to-support-continued-growth-and-ma-strategy-302773988.html
SOURCE Cathay Capital
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioMarin Announces Global Settlement with Ascendis Pharma A/S; Ascendis Will Pay Royalties to BioMarin on Yuviwel Sales in U.S., EU, Brazil and South Korea
- HUAWEI WATCH D3 Makes Early Debut at ESC Congress 2026: A New Era in Wrist-Based Blood Pressure Management
- SWI becomes an NVIDIA Cloud Partner (NCP)
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share